Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Bader, Michael Prof. Dr. (8) Bähring, Sylvia Dr. (5) Birchmeier, Walter Prof. Dr. (5) Birchmeier-Kohler, Carmen Prof. Dr. (7) Dechend, Ralf Priv. Doz. (4) Falcke, Martin Prof. Dr. (2) Fielitz, Jens Dr. (1) Gerhardt, Holger Prof. Dr. (1) Gotthardt, Michael Prof. Dr. (1) Höpken, Uta Elisabeth PD Dr. (2) Hübner, Norbert Prof. Dr. (5) Ivics, Zoltan Dr. (3) Izsvak, Zsuzsanna Dr. (4) Jentsch, Thomas Prof. Dr. (12) Kettenmann, Helmut Prof. Dr. (15) Kettritz, Ralph Prof. Dr. (1) Klußmann, Enno PD Dr. (2) Kocks, Christine Dr. (1) Kühn, Ralf Dr. (5) Lee, Young-Ae Prof. Dr. (2) Leutz, Achim Prof. Dr. (4) Lewin, Gary Prof. Dr. (5) Luft, Friedrich Prof. Dr. (53) Morano, Ingo Prof. Dr. (11) Müller, Dominik Prof. Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Rahn, Hans-Peter Dr. (1) Rajewsky, Klaus Prof. Dr. (2) Rajewsky, Nikolaus Prof. Dr. (1) Rathjen, Fritz Prof. Dr. (1) Sander, Maike Prof. Dr. (2) Scheidereit, Claus Prof. Dr. (4) Spuler, Simone Prof. (3) Stein, Ulrike Prof. Dr. (7) Walther, Wolfgang Prof. Dr. (7) Wanker, Erich Prof. Dr. (4) Willimsky, Gerald Dr. (1) Willnow, Thomas Prof. Dr. (4) Wolf, Jana Prof. Dr. (2) (-) Blankenstein, Thomas Prof. Dr. (9) Molekulare Immunologie und Gentherapie (9) Translationale Onkologie solider Tumore (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) (-) 1997 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2005 (10) 2006 (2) 2007 (8) 2008 (6) 2009 (4) 2010 (16) 2011 (12) 2012 (10) 2013 (17) 2014 (12) 2015 (16) 2016 (17) 2017 (18) 2018 (16) 2019 (17) 2020 (15) 2021 (19) 2022 (17) 2023 (10) 2024 (13) 9 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.1997 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 15. Oktober 1997 / J Immunol Costimulatory signals through B7.1/CD28 prevent T cell apoptosis during target cell lysis P.T. Daniel A. Kroidl S. Cayeux R.C. Bargou T. Blankenstein B. Doerken 01. Januar 1997 / Eur J Immunol Lack of correlation between rejection of tumor cells co-expressing interleukin 2 and B7.1 and vaccine efficiency S. Cayeux G. Richter C. Becker C. Beck A. Aicher A. Pezzutto B. Doerken T. Blankenstein 01. Januar 1997 / Exp Hematol Successful retroviral mediated transduction of a receptor gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells A. Aicher J. Westermann S. Cayeux G. Willimsky K. Daemen T. Blankenstein W. Uckert B. Doerken A. Pezzutto 1997 / Methods Mol Med Methods for use of cytokine gene-modified tumor cells in immunotherapy of cancer Z. Qin T. Blankenstein 01. Januar 1997 / J Immunol Influence of gene modified (IL 7, IL 4, and B7) tumor cell vaccines on tumor antigen presentation S. Cayeux G. Richter G. Noffz B. Doerken T. Blankenstein 01. Januar 1997 / Gene Ther Loss of retroviral gene expression in bone marrow reconstituted mice correlates with down regulation of gene expression in long term culture initiating cells C. Lange T. Blankenstein 01. Januar 1997 / Hum Gene Ther Transient expression of SV 40 large T antigen by Cre/LoxP mediated site specific deletion in primary human tumor cells L.P. Li P.M. Schlag T. Blankenstein 01. Januar 1997 / J Immunol Down regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10 F. Salazar-Onfray J. Charo M. Petersson S. Freland G. Noffz Z.H. Qin T. Blankenstein H.G. Ljunggren R. Kiessling 15. Juli 1997 / J Immunol Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte- macrophage colony-stimulating factor gene-modified tumor cells Z. Qin G. Noffz M. Mohaupt T. Blankenstein
15. Oktober 1997 / J Immunol Costimulatory signals through B7.1/CD28 prevent T cell apoptosis during target cell lysis P.T. Daniel A. Kroidl S. Cayeux R.C. Bargou T. Blankenstein B. Doerken
01. Januar 1997 / Eur J Immunol Lack of correlation between rejection of tumor cells co-expressing interleukin 2 and B7.1 and vaccine efficiency S. Cayeux G. Richter C. Becker C. Beck A. Aicher A. Pezzutto B. Doerken T. Blankenstein
01. Januar 1997 / Exp Hematol Successful retroviral mediated transduction of a receptor gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells A. Aicher J. Westermann S. Cayeux G. Willimsky K. Daemen T. Blankenstein W. Uckert B. Doerken A. Pezzutto
1997 / Methods Mol Med Methods for use of cytokine gene-modified tumor cells in immunotherapy of cancer Z. Qin T. Blankenstein
01. Januar 1997 / J Immunol Influence of gene modified (IL 7, IL 4, and B7) tumor cell vaccines on tumor antigen presentation S. Cayeux G. Richter G. Noffz B. Doerken T. Blankenstein
01. Januar 1997 / Gene Ther Loss of retroviral gene expression in bone marrow reconstituted mice correlates with down regulation of gene expression in long term culture initiating cells C. Lange T. Blankenstein
01. Januar 1997 / Hum Gene Ther Transient expression of SV 40 large T antigen by Cre/LoxP mediated site specific deletion in primary human tumor cells L.P. Li P.M. Schlag T. Blankenstein
01. Januar 1997 / J Immunol Down regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10 F. Salazar-Onfray J. Charo M. Petersson S. Freland G. Noffz Z.H. Qin T. Blankenstein H.G. Ljunggren R. Kiessling
15. Juli 1997 / J Immunol Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte- macrophage colony-stimulating factor gene-modified tumor cells Z. Qin G. Noffz M. Mohaupt T. Blankenstein